Showing 1,301 - 1,320 results of 229,567 for search '(( 10 ((we decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 2.12s Refine Results
  1. 1301

    Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

    Published 2015
    “…Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”
  2. 1302

    Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

    Published 2015
    “…Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”
  3. 1303

    Molecular Origin of Photovoltaic Performance in Donor-<i>block</i>-Acceptor All-Conjugated Block Copolymers by Kendall A. Smith (1477033)

    Published 2015
    “…Here, we synthesize a library of poly­(3-hexyl­thiophene) (P3HT) <i>block</i> poly­((9,9-dialkyl­fluorene)-2,7-diyl-<i>alt</i>-[4,7-bis­(alkyl­thiophen-5-yl)-2,1,3-benzo­thiadiazole]-2′,2″-diyl) (PFTBT) donor-<i>block</i>-acceptor all-conjugated block copolymers and carry out a comprehensive study of processing conditions, crystallinity, domain sizes, and side-chain structure on photovoltaic device performance. …”
  4. 1304

    Decrease in cell migration and adhesion of MCF10A cells after knockdown of <i>MYO1C</i>. by Kittichate Visuttijai (3204519)

    Published 2016
    “…A dose-dependent decrease in relative cell index response to MYO1C depletion was observed reaching to a significant value with concentrations of 5 and 10 nM of <i>MYO1C</i>-siRNA at 48 hours post-transfection compared to control cells (mock transfection). …”
  5. 1305

    The expression of proteins involved in iron transport in SK-Mel-5 cells indicates a decrease in iron stores. by Sarah Straud (245572)

    Published 2010
    “…Relative to HeLa cells, SK-Mel-5 have decreased expression of transferrin receptor and ferritin and a large increase in expression of the iron efflux protein ferroportin. …”
  6. 1306

    Reproductive transition paralleled a significant decrease in LDH5 and LDH1 expressions in nonTg hippocampus. by Fan Ding (302565)

    Published 2013
    “…<p>A. NonTg hippocampus demonstrated a an age-related decrease in LDH5 expression from 6 to 15 months of age, which was significant between 6 and 9, 9 and 12 months of age. …”
  7. 1307
  8. 1308

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    “…<div><p>HIV acquisition risk with norethisterone (NET) enanthate (NET-EN) is reportedly less than for depo-medroxyprogesterone acetate intramuscular (DMPA-IM). We investigated the effects of these progestin-only injectable contraceptives on serum testosterone and sex hormone binding globulin (SHBG) levels, since these may play a role in sexual behavior and HIV acquisition. …”
  9. 1309
  10. 1310
  11. 1311
  12. 1312
  13. 1313
  14. 1314
  15. 1315
  16. 1316

    Image_1_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  17. 1317

    Image_4_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  18. 1318

    Image_6_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  19. 1319

    Image_2_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”
  20. 1320

    Image_7_Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients.TIF by Arkadiusz Pietrasik (12879863)

    Published 2022
    “…Background<p>Catheter-directed therapies (CDT) are an alternative to systemic thrombolysis (ST) in pulmonary embolism (PE) patients, but the mortality benefit of CDT is unclear.</p>Objective<p>We conducted a systematic review with meta-analysis to compare the efficacy and safety of CDT and ST in intermediate-high and high-risk PE.…”